Quantitative detection of circulating nucleophosmin mutations DNA in the plasma of patients with acute myeloid leukemia

The aim of this study was to quantify the copies of circulating nucleophosmin (NPM) mutations DNA in the plasma of patients with acute myeloid leukemia (AML) and to explore the association of circulating NPM mutation levels with clinical characteristics.